test

Troy Wuertz

@Ikarian Capital, Llc

Latest period2024 - Q3ReportedManaged Assets$717.154MTotal holdings121
Assets growth rate24.93%Assets growth rate (2-Q avg)-6.06%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Ikarian Capital, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 121 positions.

Assets under management

The assets under management (AUM) of Ikarian Capital, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 717.154M in assets, with a quarterly growth rate of 24.93% and a 2-quarter average growth rate of -6.06%. The portfolio is managed by Troy Wuertz, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
RZLTRezolute Inc
Recent Activity
Decreased -1.82%
0.61%
$4.303M
887,230 shares@ $4.86 avg price
ABEOAbeona Therapeutics Inc
Recent Activity
Decreased -24.08%
0.52%
$3.688M
583,593 shares@ $6.33 avg price
SLRNAcelyrin Inc
Recent Activity
Decreased -54.09%
0.47%
$3.338M
677,074 shares@ $4.94 avg price
CRVOCervomed Inc
Recent Activity
Decreased -14.74%
0.42%
$2.954M
202,345 shares@ $14.6 avg price
TERNTerns Pharmaceuticals Inc
Recent Activity
Decreased -32.71%
0.36%
$2.573M
308,497 shares@ $8.35 avg price
CMPSCompass Pathways Plc
Recent Activity
Decreased -33.01%
0.18%
$1.278M
202,908 shares@ $6.3 avg price
SGMTSagimet Biosciences Inc
Recent Activity
Decreased -6.05%
0.15%
$1.074M
387,565 shares@ $2.77 avg price
JSPRJasper Therapeutics Inc
Recent Activity
Decreased -47.53%
0.15%
$1.038M
55,175 shares@ $18.82 avg price
RNACCartesian Therapeutics Inc
Recent Activity
Decreased -78.46%
0.12%
$841,352
52,193 shares@ $16.13 avg price
AVTEAerovate Therapeutics Inc
Recent Activity
Decreased -0.27%
0.11%
$769,046
367,965 shares@ $2.09 avg price